MCLAREN OAKLAND — History
CCN 230207 | 3-year financial timeline | COVID resilience: 78/100
🛡️ Public data only — no PHI permitted on this instance.
$214M
Latest Revenue (FY2022)
+8.3%
Revenue CAGR (3yr)
1.6%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $183M | $193M | $214M | +10.8% | +8.3% |
| Operating Expenses | $197M | $209M | $211M | +1.0% | +3.4% |
| Operating Margin | -8.0% | -7.9% | 1.6% | +120.7% | +0.0% |
| Net Income | $-15M | $-15M | $4M | +123.0% | +0.0% |
| Licensed Beds | 105 | 109 | 107 | -1.8% | +0.9% |
| Total Patient Days | 20,172 | 18,018 | 18,768 | +4.2% | -3.5% |
| Medicare Day % | 33% | 29% | 27% | -8.1% | -10.5% |
| Medicaid Day % | 10% | 7% | 5% | -28.1% | -28.0% |
COVID Impact & Recovery
Resilience Score: 78/100 — Resilient — strong COVID recovery
Revenue recovery from FY2020 to FY2022: +17.4% ($183M → $214M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+8.3%
This Hospital
+7.6%
State Avg
Latest Margin
1.6%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $230M | 6.4% |
| FY2024 (proj) | $246M | 11.2% |
| FY2025 (proj) | $262M | 16.0% |